Clinical trial / 2006
Plant sterol or stanol consumption for 16 weeks did not alter erythrocyte osmotic fragility in statin-treated patients.
In a double-blind, placebo-controlled trial, 41 statin-treated patients consumed a control margarine for 4 weeks and were then randomized for 16 weeks to receive daily control margarine (n=11), 2.5 g plant sterol ester-enriched margarine (n=15), or 2.5 g plant stanol ester-enriched margarine (n=15). Despite significant (P = 0.004) increases of 42% and 59% in cholesterol-standardized serum sitosterol and campesterol concentrations in the plant sterol group versus control, red blood cell campesterol levels did not change (P = 0.196). Osmotic fragility showed no significant change (P = 0.757) in either the plant sterol or stanol groups compared with controls.
- Study type
- Double-blind, randomized, placebo-controlled trial
- Who was studied
- 41 subjects on stable statin treatment
- What was measured
- Incorporation into erythrocytes and erythrocyte osmotic fragility
THE PAPER
Plant sterol or stanol consumption does not affect erythrocyte osmotic fragility in patients on statin treatment.
de Jong A, Plat J, Mensink RP. Eur J Clin Nutr, 2006.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.